maladies – Nouveaux médicaments pour la maladie d'Alzheimer

This written question concerns the availability and accessibility of new medications for Alzheimer's disease. It seeks information on the current situation and future prospects for patients in France. The question addresses the needs of patients and their families, as well as the healthcare system's capacity to integrate these innovative treatments.